Nevro Corp. (NYSE:NVRO) Q3 2023 Results Conference Call November 1, 2023 4:30 PM ET
Company Participants
Kevin Thornal - President and Chief Executive Officer
Rod MacLeod - Senior Vice President and Chief Financial Officer
Conference Call Participants
Shagun Singh - RBC Capital
Brad Bowers - Mizuho Securities
Simran Kaur - Piper Sandler
David Turkaly - JMP Securities
Operator
Hello. My name is Chris, and I will be your conference operator today. At this time, I would like to welcome everyone to Nevro Third Quarter 2023 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] Thank you.
[Ian Toll] (Ph) you may begin.
Unidentified Company Representative
Good afternoon. And welcome to Nevro’s third quarter 2023 earnings conference call. With me today are Kevin Thornal, CEO and President; and Rod MacLeod, Chief Financial Officer. On today’s Kevin will discuss third quarter business results. And Rod will conclude with detailed financials and guidance before we open up the call for questions. Please note, there are also slides available related to our Nevro’s third quarter performance on the Investor Relations website in the Events & Presentations section.
Earlier today Nevro released its financial results for the third quarter ended September 30, 2023. A copy of the earnings release is available on the Investor Relations section of Nevro website at nevro.com. This call is being broadcast live over the Internet to all interested parties on November 1, 2023 and an archived copy of this webcast will be available on Nevro’s Investor Relations website.
Before we begin, I would like to remind everyone that comments made on today’s call may include forward-looking statements within the meaning of the federal securities laws. Results could differ materially from those expressed or implied as a result of certain risks and uncertainties. Please refer to Nevro’s SEC filings including its annual report on Form 10-K filed on February 21, 2023 for a detailed presentation of risks. The forward-looking statements in this call speak only as of today, and the company undertakes no obligation to update or revise any of these statements.
In addition, management will refer to adjusted EBITDA, a non-GAAP measure used to help investors understand Nevro’s ongoing business performance. Non-GAAP adjusted EBITDA excludes interest, taxes and non-cash items such as stock-based compensation, depreciation and amortization, litigation-related expenses, certain litigation charges and credits and other adjustments, such as restructuring charges. Please refer to the GAAP to non-GAAP reconciliation tables within the earnings release.